Janus Biotherapeutics collaborating with pharmaceutical giant Roche to develop toll-like receptor (TLR) inhibitor with the potential to address several autoimmune diseases – including lupus.
Early clinical trials suggest the investigational drug blisibimod may be safe and effective in treating lupus.
As reported by Lupus Daily News, a new study published in International Journal of Molecular Sciences shows that a standard lupus treatment can affect osteoporosis.
A new study finds that Benlysta, approved for lupus, may benefit patients with Sjögren’s.
As reported by Rheumatology Network, a new study published in American Journal of Public Health reports that unfair treatment by healthcare professionals is associated with disease damage among black women.
A new study suggests a target for developing a potential lupus treatment.
Learnings from two epratuzumab studies will inform progress in this complex autoimmune disease
Text LUPUS to 50555 to donate $10 to research. Or text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.Full Terms
Visit LupusTrials.org learn about lupus clinical trials that might be right for you or a family member.
Learn about local news and events from the LRI National Coalition.
Join us at fun educational events hosted by the Center for Information & Study on Clinical Research Participation